319 results on '"Sairaku, Akinori"'
Search Results
2. A Novel Hemostatic Belt Allowing Ambulation Soon After Atrial Fibrillation Ablation
3. Progression from paroxysmal to persistent atrial fibrillation in pacemaker patients with tachycardia–bradycardia syndrome: a multicenter study
4. Impact of ABO blood type on the risk of atrial fibrillation recurrence after catheter ablation
5. Increased major bleeding incidence in atrial fibrillation patients with apixaban: a review of Japanese post-marketing surveillance studies of direct oral anticoagulants
6. Correction to: A Novel Hemostatic Belt Allowing Ambulation Soon After Atrial Fibrillation Ablation
7. Impact of SGLT2 inhibitors on old age patients with heart failure and chronic kidney disease
8. Peripheral arterial tone during active standing
9. Intra-procedural anticoagulation and post-procedural hemoglobin fall in atrial fibrillation ablation with minimally interrupted direct oral anticoagulants: comparisons across 4 drugs
10. Prolonged PR intervals are associated with epicardial adipose tissue and recurrence after catheter ablation in persistent atrial fibrillation
11. Devastating Worsening Renal Function Following the Initiation of Sacubitril/Valsartan: Falling Between Two Stools
12. Impact of Lipoprotein (a) on Long-Term Outcomes in Patients With Acute Myocardial Infarction
13. Increased Urinary Liver-Type Fatty Acid–Binding Protein Level Predicts Worsening Renal Function in Patients With Acute Heart Failure
14. Differences in prothrombotic response between the uninterrupted and interrupted apixaban therapies in patients undergoing cryoballoon ablation for paroxysmal atrial fibrillation: a randomized controlled study
15. Prognostic Significance of New-Onset Atrial Fibrillation in Patients With Non-Hodgkin's Lymphoma Treated With Anthracyclines
16. Don't expect left ventricular reverse remodeling after cardiac resynchronization therapy in patients with systolic heart failure and atrioventricular block: A multicenter study
17. Chromosome 4q25 Variant rs6817105 Bring Sinus Node Dysfunction and Left Atrial Enlargement
18. Don't move during ablation of atrial fibrillation!
19. Abstract 20513: A Common SCN10A Variant May Promote DNA Methylation of SCN5A Promoter and Decrease SCN5A Expression in Brugada Syndrome Patients Without SCN5A Exonic Mutation
20. Ablation of atrial fibrillation in Brugada syndrome patients with an implantable cardioverter defibrillator to prevent inappropriate shocks resulting from rapid atrial fibrillation
21. Clinical significance of sleep-disordered breathing induced by sedatives during ablation of atrial fibrillation
22. Correction to: Differences in prothrombotic response between the uninterrupted and interrupted apixaban therapies in patients undergoing cryoballoon ablation for paroxysmal atrial fibrillation: a randomized controlled study
23. Does atrial fibrillation ablation worsen preexisting anemia? Another anemia paradox in DOAC era
24. Periprocedural coagulability in patients undergoing ablation of atrial fibrillation: lessons from a periablation anticoagulation strategy of a brief withdrawal of warfarin without heparin bridging
25. A Head-to-Head Comparison of Periprocedural Coagulability Under Anticoagulation with Rivaroxaban Versus Dabigatran in Patients Undergoing Ablation of Atrial Fibrillation
26. Incomplete Cure of Tachycardia-Induced Cardiomyopathy Secondary to Rapid Atrial Fibrillation by Heart Rate Control Without Sinus Conversion
27. Atrioventricular conduction properties in patients with prolonged pauses undergoing ablation of longstanding persistent atrial fibrillation: do pauses during atrial fibrillation matter?
28. Rapid hemostasis at the femoral venous access site using a novel hemostatic pad containing kaolin after atrial fibrillation ablation
29. Time-Domain T-Wave Alternans is Strongly Associated with a History of Ventricular Fibrillation in Patients with Brugada Syndrome
30. Procedural sedation with dexmedetomidine during ablation of atrial fibrillation: a randomized controlled trial
31. Variable Procedural Strategies Adapted to Anatomical Characteristics in Catheter Ablation of the Cavotricuspid Isthmus Using a Preoperative Multidetector Computed Tomography Analysis
32. A Randomized Controlled Trial of Dabigatran versus Warfarin for Periablation Anticoagulation in Patients Undergoing Ablation of Atrial Fibrillation
33. Outcomes of Ablation of Paroxysmal Atrial Fibrillation in Patients on Chronic Hemodialysis
34. Prediction of sinus node dysfunction in patients with persistent atrial flutter using the flutter cycle length
35. How many electrical cardioversions should be applied for repetitive recurrences of atrial arrhythmias following ablation of persistent atrial fibrillation?
36. Intra-procedural anticoagulation and post-procedural hemoglobin fall in atrial fibrillation ablation with minimally interrupted direct oral anticoagulants: comparisons across 4 drugs
37. A smaller post-procedural hemoglobin fall in patients with preexisting anemia undergoing atrial fibrillation ablation with a single skipped dose of direct oral anticoagulants: Another anemia paradox
38. Intraprocedural anticoagulation and postprocedural hemoglobin fall in atrial fibrillation ablation with minimally interrupted direct oral anticoagulants: comparisons across 4 drugs
39. Remaining activity of temporary interrupted direct oral anticoagulants and its impact on intra‐ablation heparinization in patients with atrial fibrillation: Comparisons across four drugs and two dose regimens
40. Prognostic significance of oscillatory ventilation at rest in patients with advanced heart failure undergoing cardiopulmonary exercise testing
41. Residual anticoagulation activity in atrial fibrillation patients with temporary interrupted direct oral anticoagulants: Comparisons across 4 drugs
42. Cardiac electrophysiological characteristics of silent paroxysmal atrial fibrillation: What causes asymptomaticity?
43. A spontaneous Type 1 electrocardiogram pattern in lead V2 is an independent predictor of ventricular fibrillation in Brugada syndrome
44. Ser96Ala genetic variant of the human histidine-rich calcium-binding protein is a genetic predictor of recurrence after catheter ablation in patients with paroxysmal atrial fibrillation
45. A mimic of tachycardia‐bradycardia syndrome in a patient with long‐standing persistent atrial fibrillation
46. Additional file 3: Figure S2. of H558R, a common SCN5A polymorphism, modifies the clinical phenotype of Brugada syndrome by modulating DNA methylation of SCN5A promoters
47. Additional file 2: Figure S1. of H558R, a common SCN5A polymorphism, modifies the clinical phenotype of Brugada syndrome by modulating DNA methylation of SCN5A promoters
48. Maintenance of low inflammation level by the ZFHX3 SNP rs2106261 minor allele contributes to reduced atrial fibrillation recurrence after pulmonary vein isolation
49. HCN4 Gene Polymorphisms Are Associated With Occurrence of Tachycardia-Induced Cardiomyopathy in Patients With Atrial Fibrillation
50. Head-to-head comparison of the heart rate variability between the bisoprolol transdermal patch and bisoprolol fumarate tablet
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.